Medical devices, healthcare technology and the business of care
510(k) clearance · K243627

Laryngoscope Junctional-Arterial Restriction Clamp (L-ARC); Arterial Restriction Clamp (ARC)

Arc Trauma, LLC · Decision date Dec 31, 2025

FDA DECISIONK243627

What did the FDA decide?

FDA records K243627 as a 510(k) premarket notification, with a decision dated Dec 31, 2025. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Dec 31, 2025

FDA source record

Regulatory record facts

Identifier
K243627
Regulatory pathway
510(k) premarket notification
Product code
DXC
Decision code
SESE
Decision date
Dec 31, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Clamp, Vascular.

Product code
DXC
FDA device class
2

FDA decision timeline

  1. K243627 received

    Application receipt date recorded by FDA.

  2. K243627 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DXC

Product / regulatory recordCompanyPathwayDecision dateSource
UK Innovations, GP, Ltd.510(k) clearanceNov 6, 2026FDA
Merit Medical Systems, Inc.510(k) clearanceJul 22, 2026FDA
Edwards Lifesciences510(k) clearanceJun 5, 2026FDA
Tz Medical, Inc.510(k) clearanceMay 22, 2026FDA
TW Medical510(k) clearanceApr 3, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arc Trauma, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Jamestown, OH

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records